Cite
HARVARD Citation
Bhardwaj, N. et al. (n.d.). Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]. Journal for immunotherapy of cancer. p. . [Online].